| 000 | 01485 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516003457.0 | ||
| 264 | 0 | _c20110214 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1754-8411 | ||
| 024 | 7 |
_a10.1242/dmm.006312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSträhle, Uwe | |
| 245 | 0 | 0 |
_aThe zebrafish embryo as a model for assessing off-target drug effects. _h[electronic resource] |
| 260 |
_bDisease models & mechanisms _c |
||
| 300 |
_a689-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzothiazoles _xpharmacology |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aEmbryo, Nonmammalian _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aToluene _xanalogs & derivatives |
| 650 | 0 | 4 | _aTumor Protein p73 |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aZebrafish _xembryology |
| 700 | 1 | _aGrabher, Clemens | |
| 773 | 0 |
_tDisease models & mechanisms _gvol. 3 _gno. 11-12 _gp. 689-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1242/dmm.006312 _zAvailable from publisher's website |
| 999 |
_c20204975 _d20204975 |
||